Vaxess is developing revolutionary technologies to change the way we receive vaccines and expand access to healthcare products.
Location: United States, Massachusetts, Boston
Total raised: $83.25M
Investors 3
Funding Rounds 6
| Date | Series | Amount | Investors |
| 13.09.2023 | - | $9M | - |
| 26.01.2023 | Series B | $10M | Mission Bi... |
| 03.11.2022 | Series B | $27M | - |
| 14.05.2021 | - | $25.3M | - |
| 01.07.2019 | Series A | $8.2M | - |
| 23.05.2013 | Series A | $3.75M | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 13.09.2023 | Vaxess Technologies Raises $9M in Funding | Vaxess Technologies, Inc., a Cambridge, MA-based life sciences company developing a shelf-stable vac... | finsmes.co... |
| 11.01.2023 | Vaxess Raises Additional $10M for Needle-Free Vaccine Patche... | Photo: Vaxess / Facebook Vaxess is a Cambridge-based life sciences company developing a shelf-stabl... | builtinbos... |
| 10.01.2023 | Vaxess Raises Additional $10M in Funding | Vaxess, a Cambridge, MA-based life sciences company developing a shelf-stable vaccine patch with pot... | finsmes.co... |
| 03.11.2022 | Vaxess Raises $27M in Series B Funding | Vaxess Technologies, a Cambridge, MA-based life sciences company developing a sustained-release vacc... | finsmes.co... |
| 29.01.2021 | Ted Hibben joins Vaxess as Chief Business Officer | Vaxess Logo As Vaxess moves the first program into the clinic, we’re excited to work with Ted to exp... | prweb.com/... |
| 01.07.2019 | Vaxess Technologies Closes Final Tranche of $8.2M Series A F... | Vaxess Technologies, a Cambridge, MA-based biotechnology company, closed the final tranche of an $8.... | finsmes.co... |
| 28.06.2019 | Term Sheet — Friday June 28 | APPLE’S AUTONOMOUS VEHICLE AMBITIONS Hello Term Sheet readers. Lucinda here again until Polina’s re... | fortune.co... |
| 28.06.2019 | Boston Tech Watch: Vaxess, Fusion Power, Wayfair & MassC... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints An acquisition, accelerator awards... | xconomy.co... |
| 27.06.2019 | Vaxess Technologies Closes Final Tranche of $8.2 Million Ser... | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vaxess Technologies, a biotechnology company redefining drug deli... | citybizlis... |
| 21.10.2015 | Spinning health solutions from silk | When Dr. Ailis Tweed-Kent was an internal medicine resident at Massachusetts General Hospital, she s... | statnews.c... |
Show more